The loss of FXR signalling impairs hepatic glucose homeostasis and decreases insulin sensitivity, while FXR activation improves hyperglycaemia and hyperlipidaemia in diabetic mice.11, 12. This evidence concerns the gene INS and hyperlipidemia.